Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
2.820
-0.050 (-1.74%)
At close: Jun 26, 2026, 4:00 PM EDT
2.800
-0.020 (-0.71%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Altimmune Market Cap
Altimmune has a market cap or net worth of $548.42 million as of June 26, 2026. Its market cap has increased by 3.39% in one year.
Market Cap
548.42M
Enterprise Value
252.72M
1-Year Change
3.39%
Ranking
Category
Stock Price
$2.82
Market Cap Chart
Since May 5, 2017, Altimmune's market cap has decreased from $2.19B to $548.42M, a decrease of -74.97%. That is a compound annual growth rate of -14.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 548.42M | 39.17% |
| Dec 31, 2025 | 394.05M | -23.16% |
| Dec 31, 2024 | 512.81M | -15.16% |
| Dec 29, 2023 | 604.45M | -25.23% |
| Dec 30, 2022 | 808.45M | 122.62% |
| Dec 31, 2021 | 363.14M | -12.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gyre Therapeutics | 574.73M |
| First Tracks Biotherapeutics | 559.32M |
| ProKidney | 552.77M |
| REGENXBIO | 541.79M |
| Contineum Therapeutics | 530.51M |
| Assembly Biosciences | 529.91M |
| XOMA Royalty | 528.60M |
| Rezolute | 526.51M |